O'Neill BV - Search Results

1

The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction.

Nathan PJ, Watson J, Lund J, Davies CH, Peters G, Dodds CM, Swirski B, Lawrence P, Bentley GD, O'Neill BV, Robertson J, Watson S, Jones GA, Maruff P, Croft RJ, Laruelle M, Bullmore ET. Nathan PJ, et al. Int J Neuropsychopharmacol. 2013 May;16(4):721-31. doi: 10.1017/S1461145712000752. Epub 2012 Aug 29. Int J Neuropsychopharmacol. 2013. PMID: 22932339 Free article. Clinical Trial.

2

The effects of the dopamine D₃ receptor antagonist GSK598809 on attentional bias to palatable food cues in overweight and obese subjects.

Nathan PJ, O'Neill BV, Mogg K, Bradley BP, Beaver J, Bani M, Merlo-Pich E, Fletcher PC, Swirski B, Koch A, Dodds CM, Bullmore ET. Nathan PJ, et al. Int J Neuropsychopharmacol. 2012 Mar;15(2):149-61. doi: 10.1017/S1461145711001052. Epub 2011 Jul 12. Int J Neuropsychopharmacol. 2012. PMID: 21745436 Free article. Clinical Trial.

3

Neuropsychiatric adverse effects of centrally acting antiobesity drugs.

Nathan PJ, O'Neill BV, Napolitano A, Bullmore ET. Nathan PJ, et al. CNS Neurosci Ther. 2011 Oct;17(5):490-505. doi: 10.1111/j.1755-5949.2010.00172.x. Epub 2010 Jul 7. CNS Neurosci Ther. 2011. PMID: 21951371 Free PMC article. Review.

4

Multiple-dose safety, pharmacokinetics, and pharmacodynamics of the μ-opioid receptor inverse agonist GSK1521498.

Nathan PJ, Bush MA, Tao WX, Koch A, Davies KM, Maltby K, O'Neill BV, Napolitano A, Skeggs AL, Brooke AC, Richards DB, Williams PM, Bullmore ET. Nathan PJ, et al. J Clin Pharmacol. 2012 Oct;52(10):1456-67. doi: 10.1177/0091270011421785. Epub 2011 Dec 12. J Clin Pharmacol. 2012. PMID: 22162534 Clinical Trial.

5

The effects of GSK2981710, a medium-chain triglyceride, on cognitive function in healthy older participants: A randomised, placebo-controlled study.

O'Neill BV, Dodds CM, Miller SR, Gupta A, Lawrence P, Bullman J, Chen C, Dewit O, Kumar S, Dustagheer M, Price J, Shabbir S, Nathan PJ. O'Neill BV, et al. Hum Psychopharmacol. 2019 May;34(3):e2694. doi: 10.1002/hup.2694. Hum Psychopharmacol. 2019. PMID: 31124194 Clinical Trial.

6

Direct evidence that acutely enhancing serotonin with the selective serotonin reuptake inhibitor citalopram modulates the loudness dependence of the auditory evoked potential (LDAEP) marker of central serotonin function.

Nathan PJ, Segrave R, Phan KL, O'Neill B, Croft RJ. Nathan PJ, et al. Hum Psychopharmacol. 2006 Jan;21(1):47-52. doi: 10.1002/hup.740. Hum Psychopharmacol. 2006. PMID: 16317803 Clinical Trial.

7

Effect of the dopamine D3 receptor antagonist GSK598809 on brain responses to rewarding food images in overweight and obese binge eaters.

Dodds CM, O'Neill B, Beaver J, Makwana A, Bani M, Merlo-Pich E, Fletcher PC, Koch A, Bullmore ET, Nathan PJ. Dodds CM, et al. Appetite. 2012 Aug;59(1):27-33. doi: 10.1016/j.appet.2012.03.007. Epub 2012 Mar 21. Appetite. 2012. PMID: 22445776 Clinical Trial.

8

High-dose glycine impairs the prepulse inhibition measure of sensorimotor gating in humans.

O'Neill BV, Croft RJ, Mann C, Dang O, Leung S, Galloway MP, Phan KL, Nathan PJ. O'Neill BV, et al. J Psychopharmacol. 2011 Dec;25(12):1632-8. doi: 10.1177/0269881110372546. Epub 2010 Jul 8. J Psychopharmacol. 2011. PMID: 20615931 Clinical Trial.

9

Acute serotonin and dopamine depletion improves attentional control: findings from the stroop task.

Scholes KE, Harrison BJ, O'Neill BV, Leung S, Croft RJ, Pipingas A, Phan KL, Nathan PJ. Scholes KE, et al. Neuropsychopharmacology. 2007 Jul;32(7):1600-10. doi: 10.1038/sj.npp.1301262. Epub 2006 Dec 6. Neuropsychopharmacology. 2007. PMID: 17151596 Clinical Trial.

10

Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humans.

Mann C, Croft RJ, Scholes KE, Dunne A, O'Neill BV, Leung S, Copolov D, Phan KL, Nathan PJ. Mann C, et al. Neuropsychopharmacology. 2008 Jun;33(7):1653-66. doi: 10.1038/sj.npp.1301556. Epub 2007 Sep 26. Neuropsychopharmacology. 2008. PMID: 17895917 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters